Gene · 5406
Papers3,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacologic Management of Obesity after Liver Transplantation: A Critical Review. | Ann Gastroenterol Dig Disord | 2023 | 38098758 | PubTator, text mining | PubMed |
| Comparative gut proteomics study revealing adaptive physiology of Eurasian spruce bark beetle, Ips typographus (Coleoptera: Scolytinae). | Front Plant Sci | 2023 | 38078109 | PubTator, text mining | PubMed |
| Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review. | Saudi Pharm J | 2023 | 38053738 | PubTator, text mining | PubMed |
| A narrative review on the role of genetics in children with acute recurrent pancreatitis and chronic pancreatitis. | Pediatr Investig | 2023 | 38050536 | PubTator, text mining | PubMed |
| The role of human milk fats in shaping neonatal development and the early life gut microbiota. | Microbiome Res Rep | 2023 | 38047278 | PubTator, text mining | PubMed |
| Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS). | Front Pharmacol | 2023 | 38044938 | PubTator, text mining | PubMed |
| The natural compound Sanggenon C inhibits PRRSV infection by regulating the TRAF2/NF-κB signalling pathway. | Vet Res | 2023 | 38037100 | PubTator, text mining | PubMed |
Effects of green coffee aqueous extract supplementation on glycemic indices, lipid profile, CRP, and malondialdehyde in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. | Front Nutr | 2023 | 38035358 | PubTator, text mining | PubMed |
| Endoscopic Removal of a Recurrent Trichobezoar in an Adolescent: A Case Report. | JPGN Rep | 2023 | 38034449 | PubTator, text mining | PubMed |
| Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment. | Lipids Health Dis | 2023 | 38031159 | PubTator, text mining | PubMed |
| In Silico and In Vitro Analyses to Repurpose Quercetin as a Human Pancreatic α-Amylase Inhibitor. | ACS Omega | 2023 | 38027372 | PubTator, text mining | PubMed |
| Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model. | Front Endocrinol (Lausanne) | 2023 | 38027148 | PubTator, text mining | PubMed |
| Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases. | Front Pharmacol | 2023 | 38027005 | PubTator, text mining | PubMed |
| Antioxidant and antidiabetic activity and phytoconstituents of lichen extracts with temperate and polar distribution. | Front Pharmacol | 2023 | 38026927 | PubTator, text mining | PubMed |
| Genetics and Genomics of Chronic Pancreatitis with a Focus on Disease Biology and Molecular Pathogenesis. | Glob Med Genet | 2023 | 38025192 | PubTator, text mining | PubMed |
| Single anthocyanins effectiveness modulating inflammation markers in obesity: dosage and matrix composition analysis. | Front Nutr | 2023 | 38024376 | PubTator, text mining | PubMed |
| Extraction, functionality, and applications of Chlorella pyrenoidosa protein/peptide. | Curr Res Food Sci | 2023 | 38021256 | PubTator, text mining | PubMed |
| Glutathione Peroxidase-like Antioxidant Activity of 1,3-Benzoselenazoles: Synthesis and In Silico Molecular Docking Studies as Pancreatic Lipase Inhibitors. | J Org Chem | 2023 | 38008916 | PubTator, text mining | PubMed |
| A Review of the Role of an Anthocyanin, Cyanidin-3-O-β-glucoside in Obesity-Related Complications. | Plants (Basel) | 2023 | 38005786 | PubTator, text mining | PubMed |
| Stevia Polyphenols, Their Antimicrobial and Anti-Inflammatory Properties, and Inhibitory Effect on Digestive Enzymes. | Molecules | 2023 | 38005293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5406/papers?page=18